Hanns Lochmuller Person-Info 

( Ich bin Hanns Lochmuller)

News

(1 - 4 von 11
)

AMO Pharma Initiates Phase 2 Clinical Trial in UK for AMO-02 for...

www.finanznachrichten.de
Study represents first sponsor-led clinical research program forpatients withcongenital and juvenile onset myotonic dystrophy LONDON and PHILADELPHIA, Aug....

AMO Pharma Initiates Phase 2 Clinical Trial in UK for AMO-02 for ...www.prnewswire.co.uk › news-releases › amo-phar...

www.prnewswire.co.uk
· ... the principal investigator professor Hanns Lochmuller, chair of experimental myology at Newcastle University Institute for Genetic Medicine.

Spinal muscular atrophy workshop | European Medicines Agency

www.ema.europa.eu
Presentation - Registries and trial readiness (Hanns Lochmuller), (English only), Presentation - Regulatory perspective (Mario Miguel Rosa) ...

DNA database aims to help identify rare, mysterious genetic disorders...

www.ctvnews.ca
A new website spearheaded by Canadian researchers is being launched worldwide in an effort to speed the discovery of genes responsible for rare disorders.
Dossier exportieren
+1